A higher dose and shorter treatment time of a cornerstone tuberculosis (TB) drug has proven to be safe for patients, according to a clinical trial led by researchers at St George's, University of London. Results have been ...
Aug 29, 2023
0
17
Researchers at the University of Colorado Anschutz Medical Campus have officially identified a central conduit to obesity: fructose.
Aug 1, 2023
0
168
The RNF41 protein could be a new therapeutic target in the fight against two chronic liver diseases: cirrhosis and liver inflammation. This is the conclusion of a study published in the journal Science Translational Medicine ...
Jul 28, 2023
0
340
A protein responsible for lethal liver disease in mice infected with Rift Valley fever virus (RVFV) has been identified by scientists at the University of Pittsburgh Center for Vaccine Research. These results from new research ...
Jul 26, 2023
0
38
Doctors in Seattle are reporting a history-making case in which a patient received two donor organs, a liver and a heart, to prevent the extreme likelihood that her body would reject a donor heart transplanted alone. In this ...
Jul 13, 2023
0
94
A mechanism underlying several liver diseases involves bile produced in the liver that cannot be secreted into the intestine as intended. This leads to a backlog of bile, which can damage the liver tissue.
Jul 3, 2023
0
72
While cancer mortality rates in the U.S. have decreased, cancer remains the leading cause of death among Hispanic individuals, who generally having lower cancer incidence compared to non-Hispanic white individuals.
Jun 29, 2023
0
27
Stanford Medicine researchers have found that a common blood condition associated with several diseases may have a protective effect against Alzheimer's disease.
Jun 28, 2023
0
78
Yale researchers have found that liver fibrosis—scarring of the liver tissue that occurs in many chronic liver diseases—is associated with reduce cognitive ability and, in certain regions of the brain, reduced brain volume. ...
Jun 26, 2023
0
86
Targeting a master-regulator of inflammation with a monoclonal antibody potentially improves two unrelated conditions that currently have limited treatment options: preterm births and fatty liver disease, two new studies ...
Jun 22, 2023
0
81
